Tag Archives: EXTN

Best Tech Stocks To Invest In Right Now

Cryptocurrency markets might be cooling off, but the hype around blockchain isnt abating, judging by the popularity of exchange-traded funds centered on the technology. Four new ETFs, all promising to give investors exposure to blockchain technology, launched in January. The latest is the Innovation Shares NextGen Protocol ETF, which trades under the ticker KOIN KOIN, […]

Top 10 Casino Stocks To Buy Right Now

Michael E. Lewitt Back in April, I recommendedCaesars Entertainment Corp.(Nasdaq: CZR) as a buy – but warned you that this was a play that might take some time to mature. If you haven’t gotten in already, you’ll want to do it soon. After months of bitter wrangling, the much-beleaguered Caesars has finally reached a $5 […]

Top Biotech Stocks To Invest In 2018

Biotech company Bioverativ Inc (NASDAQ:BIVV) is being acquired by Sanofi SA (ADR) (NYSE:SNY) for $11.6 billion in cash. The deal puts a 64% premium on the price of BIVV stock, which was up 61% in pre-market activity at 5:15 a.m. today. Source: Shutterstock Bioverativ focuses on the discovery, research, development, and commercialization of innovative therapies for the […]

Top 5 Warren Buffett Stocks To Watch For 2018

&l;p&g;&l;img class=&q;dam-image getty size-large wp-image-849890494&q; src=&q;https://specials-images.forbesimg.com/dam/imageserve/849890494/960×0.jpg?fit=scale&q; data-height=&q;655&q; data-width=&q;960&q;&g; (Photo by Daniel Zuchnik/WireImage) It&a;rsquo;s happening again: blood is in the streets. And if you remember the timeless advice of Warren Buffett, you know what to do: be greedy. Because this selloff shouldn&a;rsquo;t be happening (I&a;rsquo;ll show you why in just a couple paragraphs)&a;mdash;and as a result, […]

Hot Tech Stocks To Invest In 2018

Spark Therapeutics (NASDAQ: ONCE) is a primary gene therapy company to address patients suffering from inherited retinal disease (IRD), hemophilia and neurodegenerative diseases. The company presented the cumulative 1-year follow-up Phase 1/2 data of SPK-9001 infusion for the treatment of hemophilia B and preliminary on SPK-8011 Phase 1/2 dose-escalation clinical trial in hemophilia A at […]